0 CHECKOUT

Analgesics - USA

  • ID: 1572715
  • February 2011
  • Region: United States
  • 47 pages
  • Euromonitor International
1 of 3

The key story in analgesics in 2010 was Johnson & Johnson’s recall of many major brands. In nearly every month from January to October, Johnson & Johnson instituted recalls affecting numerous lots of both children’s and adult Tylenol, Motrin and St Joseph products. The source of these recalls was a series of cGMP violations, and problems ranged from products having a musty or mouldy odour to liquid medications containing particulates. In an attempt to address these quality concerns, McNeil...

The Analgesics in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Analgesics in the US
Euromonitor International
February 2011
List of Contents and Tables
Executive Summary
Consumer Health Industry Remains Vital
Market Leader Hit by Series of Product Recalls
Private Label Growth Continues
In-store Clinics Help Drive Retail Sales
Challenges Threaten Future Industry Growth
Key Trends and Developments
Johnson & Johnson Initiates A Series of Major Product Recalls
Debate Surrounds the Abuse Potential of Major Drugs
US Passes Landmark Healthcare Reform Law
Ageing Population Drives Growth Through Otc, Vitamins and Dietary Supplements and Sports Nutrition
Retail Health Clinics Continue To Grow
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
Table 2 Life Expectancy at Birth 2005-2010
Market Data
Table 3 Sales of Consumer Health by Category: Value 2005-2010
Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
Table 5 Consumer Health Company Shares by Value 2006-2010
Table 6 Consumer Health Brand Shares by Value 2007-2010
Table 7 Penetration of Private Label by Category 2005-2010
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2008-2010
Definitions
Summary 2 Research Sources
Adams Respiratory Therapeutics Inc
Strategic Direction
Key Facts
Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Adams Respiratory Therapeutics Inc: Competitive Position 2010
Bayer Corp
Strategic Direction
Key Facts
Summary 5 Bayer Corp: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 Bayer Corp: Competitive Position 2010
Chattem Inc
Strategic Direction
Key Facts
Summary 7 Chattem Inc: Key Facts
Summary 8 Chattem Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Chattem Inc: Competitive Position 2010
General Nutrition Centers Inc
Strategic Direction
Key Facts
Summary 10 General Nutrition Centers Inc: Key Facts
Summary 11 General Nutrition Centers Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 General Nutrition Centers Inc: Competitive Position 2010
GlaxoSmithKline Consumer Health
Strategic Direction
Key Facts
Summary 13 GlaxoSmithKline Consumer Health: Key Facts
Company Background
Production
Competitive Positioning
Summary 14 GlaxoSmithKline Consumer Health: Competitive Position 2010
Mcneil Consumer & Specialty Pharmaceuticals
Strategic Direction
Key Facts
Summary 15 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
Company Background
Production
Competitive Positioning
Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2010
Melaleuca Inc
Strategic Direction
Key Facts
Summary 17 Melaleuca Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 18 Melaleuca Inc: Competitive Position 2010
Nature's Sunshine Products Inc
Strategic Direction
Key Facts
Summary 19 Nature's Sunshine Products Inc: Key Facts
Summary 20 Nature's Sunshine Products Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 21 Nature's Sunshine Products Inc: Competitive Position 2010
Pfizer Consumer Healthcare Inc
Strategic Direction
Key Facts
Summary 22 Pfizer Consumer Healthcare Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 23 Pfizer Consumer Healthcare Inc: Competitive Position 2010
Wal-mart Stores Inc
Strategic Direction
Key Facts
Summary 24 Wal-Mart Stores Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 25 Wal-Mart Stores: Competitive Position 2010
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Analgesics by Category: Value 2005-2010
Table 13 Sales of Analgesics by Category: % Value Growth 2005-2010
Table 14 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
Table 15 Analgesics Company Shares by Value 2006-2010
Table 16 Analgesics Brand Shares by Value 2007-2010
Table 17 Forecast Sales of Analgesics by Category: Value 2010-2015
Table 18 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Baxter International Inc.
  • Endo International Plc.
  • Medtronic, Inc.
  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Purdue Pharma L.P.